Renaissance Technologies TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 269 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Renaissance Technologies ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2022$36,953
-6.9%
2,849,100
+0.7%
0.05%
+10.6%
Q2 2022$39,709
+39.1%
2,828,300
+41.9%
0.05%
+42.4%
Q1 2022$28,543
+21.8%
1,993,200
+16.0%
0.03%
+13.8%
Q4 2021$23,427
-33.7%
1,718,800
-20.3%
0.03%
-37.0%
Q3 2021$35,330
-8.6%
2,156,900
-6.1%
0.05%
-4.2%
Q2 2021$38,659
-38.4%
2,297,000
-33.1%
0.05%
-38.5%
Q1 2021$62,716
-38.2%
3,434,600
-38.4%
0.08%
-29.1%
Q4 2020$101,532
-0.8%
5,578,700
-2.8%
0.11%
+7.8%
Q3 2020$102,343
+1.8%
5,736,707
+2.3%
0.10%
+17.2%
Q2 2020$100,546
+76.0%
5,607,700
+49.0%
0.09%
+58.2%
Q1 2020$57,128
+44.2%
3,763,400
+87.4%
0.06%
+83.3%
Q4 2019$39,622
+35.2%
2,008,189
+17.8%
0.03%
+20.0%
Q3 2019$29,316
+114.0%
1,704,400
+120.3%
0.02%
+108.3%
Q2 2019$13,696773,8000.01%